CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 3 filers reported holding CASI PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $0 | – | 181 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 181 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 181 | -96.0% | 0.00% | – |
| Q2 2021 | $7,000 | -50.0% | 4,494 | -27.3% | 0.00% | – |
| Q1 2021 | $14,000 | -6.7% | 6,184 | +19.8% | 0.00% | – |
| Q4 2020 | $15,000 | – | 5,164 | +3342.7% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 150 | -99.1% | 0.00% | – |
| Q2 2020 | $44,000 | -42.9% | 17,615 | -53.5% | 0.00% | – |
| Q1 2020 | $77,000 | +20.3% | 37,889 | +82.0% | 0.00% | – |
| Q4 2019 | $64,000 | +8.5% | 20,814 | +18.0% | 0.00% | – |
| Q3 2019 | $59,000 | +5.4% | 17,635 | +0.5% | 0.00% | – |
| Q2 2019 | $56,000 | +12.0% | 17,545 | -0.5% | 0.00% | – |
| Q1 2019 | $50,000 | -31.5% | 17,635 | -2.4% | 0.00% | – |
| Q4 2018 | $73,000 | -18.0% | 18,069 | -5.3% | 0.00% | – |
| Q3 2018 | $89,000 | -38.2% | 19,088 | +8.7% | 0.00% | – |
| Q2 2018 | $144,000 | +94.6% | 17,559 | +0.1% | 0.00% | – |
| Q1 2018 | $74,000 | +27.6% | 17,545 | -0.6% | 0.00% | – |
| Q4 2017 | $58,000 | +87.1% | 17,649 | +0.4% | 0.00% | – |
| Q3 2017 | $31,000 | +72.2% | 17,572 | +0.2% | 0.00% | – |
| Q2 2017 | $18,000 | -28.0% | 17,545 | -0.2% | 0.00% | – |
| Q1 2017 | $25,000 | +13.6% | 17,572 | -10.3% | 0.00% | – |
| Q4 2016 | $22,000 | +4.8% | 19,589 | +0.1% | 0.00% | – |
| Q3 2016 | $21,000 | -4.5% | 19,571 | +0.1% | 0.00% | – |
| Q2 2016 | $22,000 | +22.2% | 19,544 | +11.4% | 0.00% | – |
| Q1 2016 | $18,000 | +5.9% | 17,545 | +0.1% | 0.00% | – |
| Q4 2015 | $17,000 | – | 17,536 | +11993.8% | 0.00% | – |
| Q3 2015 | $0 | – | 145 | 0.0% | 0.00% | – |
| Q2 2015 | $0 | – | 145 | 0.0% | 0.00% | – |
| Q1 2015 | $0 | – | 145 | 0.0% | 0.00% | – |
| Q4 2014 | $0 | – | 145 | 0.0% | 0.00% | – |
| Q3 2014 | $0 | – | 145 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $23,522,000 | 27.18% |
| Consonance Capital Management LP | 7,576,431 | $22,350,000 | 2.09% |
| Wellington Shields & Co., LLC | 1,812,769 | $5,348,000 | 1.92% |
| Wellington Shields Capital Management, LLC | 2,071,765 | $6,112,000 | 0.82% |
| Ikarian Capital, LLC | 1,268,154 | $3,741,000 | 0.16% |
| Sio Capital Management, LLC | 203,432 | $600,000 | 0.12% |
| Zebra Capital Management LLC | 11,182 | $33,000 | 0.04% |
| FEDERATED HERMES, INC. | 7,000,000 | $20,650,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,146 | $154,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 161,949 | $478,000 | 0.02% |